Cargando…
Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence
Self-terminating atrial arrhythmias are commonly detected on continuous rhythm monitoring, e.g. by pacemakers or defibrillators. It is unclear whether the presence of these arrhythmias has therapeutic consequences. We sought to summarize evidence on the prevalence of atrial high-rate episodes (AHREs...
Autores principales: | Bertaglia, Emanuele, Blank, Benjamin, Blomström-Lundqvist, Carina, Brandes, Axel, Cabanelas, Nuno, Dan, G -Andrei, Dichtl, Wolfgang, Goette, Andreas, de Groot, Joris R, Lubinski, Andrzej, Marijon, Eloi, Merkely, Béla, Mont, Lluis, Piorkowski, Christopher, Sarkozy, Andrea, Sulke, Neil, Vardas, Panos, Velchev, Vasil, Wichterle, Dan, Kirchhof, Paulus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788209/ https://www.ncbi.nlm.nih.gov/pubmed/31377792 http://dx.doi.org/10.1093/europace/euz172 |
Ejemplares similares
-
The influence of atrial high-rate episodes on stroke and cardiovascular death: an update
por: Toennis, Tobias, et al.
Publicado: (2023) -
Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non–vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH–AFNET 6) trial
por: Kirchhof, Paulus, et al.
Publicado: (2017) -
Atrial high-rate episodes and stroke prevention
por: Camm, A. John, et al.
Publicado: (2017) -
Corrigendum to: Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST-AFNET 4 trial
por: Metzner, Andreas, et al.
Publicado: (2021) -
Anticoagulation, therapy of concomitant conditions, and early rhythm control
therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4
trial
por: Metzner, Andreas, et al.
Publicado: (2021)